CT Findings in Surgically Treated Focal Pancreatic Disease- A Retrospective Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06699667

Enrollment

Registered

2024-11-21

Start date

2010-01-01

Completion date

2021-12-31

Last updated

2024-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Pancreatitis

Keywords

autoimmune pancreatitis, pancreatic ductal adenocarcinoma, radiology

Brief summary

To retrospectively investigate CT imaging features of autoimmune and chronic pancreatitis (AIP and CP) mimicking pancreatic ductal adenocarcinoma in surgically resected patients.

Interventions

DIAGNOSTIC_TESTComputed tomography

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Definite diagnosis of autoimmune pancreatits or adenocarcinoma

Exclusion criteria

* No surgery

Design outcomes

Primary

Measure	Time frame	Description
Imaging features of autoimmune pancreatitis	Time frame for each study object is the time between tumor board conference and surgery - typically 2-4 weeks	Patients with a final histopathological diagnosis of autoimmune pancreatitis is identified from pancreatic surgery database and compared with matched control groups. Imaging features available at the primary tumor board conference are evaluated blinded to the final diagnosis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026